Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (2013 - 2025)

Corbus Pharmaceuticals Holdings' Free Cash Flow history runs 13 years deep, the most recent figure standing at -$15.6 million for Q3 2025.

• In Q3 2025, Free Cash Flow fell 11.53% year-over-year to -$15.6 million; the TTM figure through Dec 2025 stood at -$48.6 million (down 16.81% YoY), while the FY2024 annual figure was -$41.6 million, down 15.0% from the prior year.
• Free Cash Flow for Q3 2025 stood at -$15.6 million, up from -$16.6 million in the prior quarter.
• The five-year high for Free Cash Flow was $856954.0 in Q3 2021, with the low at -$21.8 million in Q1 2021.
• The 5-year median for Free Cash Flow is -$10.6 million (2022), against an average of -$11.2 million.
• The sharpest annual moves came in 2021 and 2022: Free Cash Flow jumped 103.14% in 2021, then sank 945.44% in 2022.
• Corbus Pharmaceuticals Holdings' Free Cash Flow stood at -$9.8 million in 2021, then rose by 23.59% to -$7.5 million in 2022, then climbed by 19.26% to -$6.0 million in 2023, then slumped by 81.79% to -$10.9 million in 2024, then sank by 42.11% to -$15.6 million in 2025.
• Business Quant data shows CRBP's Free Cash Flow at -$15.6 million in Q3 2025, -$16.6 million in Q2 2025, and -$16.4 million in Q1 2025.